April 15-17

Oxford, UK


Get updates

Subscribe to our mailing list

* indicates required

Day 1 - April 15, 2015

(download printable program here)

Time
 
12:30pm Registration and Networking
1:35pm Peter Donnelly, FRS, FMedSci, Director, Wellcome Trust Centre for Human Genetics, Oxford University

Opening words

1:40pm Jonathan Sheldon, Ph.D., Global Vice President Health Sciences, Oracle

Opening words

1:45pm Eric D. Green, M.D., Ph.D., Director, National Human Genome Research Institute

The U.S. Precision Medicine Initiative: Early Vision, Initial Planning

2:15pm Sir John Bell, GBE, FRS, HonFREng, FMedSci, Regius Professor of Medicine, University of Oxford

Precision Medicine- A Twenty Year Perspective

2:45pm Sir John Chisholm, FREng, CEng, FIEE, Executive Chair, Genomics England

International Initiatives in Personalised Medicine; the 100,000 Genome Project

3:15pm Break
Personalized Therapies
3:45pm Daphna Laifenfeld, Ph.D., Director, Personalized Medicine and Pharmacogenomics, Teva Pharmaceutical Industries Ltd

Characterizing Pharmaceuticals to Optimize Patients' Health Management

4:05pm Sally John, Ph.D., VP Genomics and Computational Biology, Biogen Idec

The Application of Human Genetics to Drug Discovery

4:25pm Munir Pirmohamed, Ph.D., FRCP, NHS Chair of Pharmacogenetics, University of Liverpool

Drugs and Genes – A Two Way Interaction

4:45pm Stephan Beck, Ph.D., FMedSci, Professor of Medical Genomics, University College London (UCL) Cancer Institute

PGP: Open Access Personal and Medical Genomics

5:05pm Jonathan K.C. Knowles , Ph.D., Executive Chairman, Immunocore

Personalisation of Medicine is Essential for Progress - How Can We Accelerate Implementation for Patients

5:30pm Break
Luminary Reception
7:00pm Cocktails and Networking - See agenda
7:45pm Ceremony Honoring Jonathan Knowles
8:30pm Closing

Day 2 - April 16, 2015

Time
 
8:30am Registration and Networking
8:55am Opening Words
Personalized Oncology Care
9:00am Nazneen Rahman, M.D., Ph.D., Head of Cancer Genetics, Institute of Cancer Research and Royal Marsden Hospital

Mainstreaming Genetic Testing in Cancer Patients

9:20am Peter Paul Yu, M.D., President, ASCO

Personalized Cancer Care: From Testing to Application

9:40am Gary Middleton, Ph.D., FRCP, Professor of Medical Oncology, University of Birmingham

Precision Medicine Trials in Non-Small Cell Lung Cancer

Overcoming the Challenges to Enable Clinical Genomics
10:00am Dirk J. Evers, Ph.D., SVP Alliance Management, Molecular Health

Comprehensive Treatment Decision Support: The Keystone of Personalized Medicine

10:15am Corina Shtir, Ph.D., Director of Population Genomics, Thermo Fisher

Personalized Clinical Genomics

10:30am Break, Exhibition & Networking
Health Economics and Reimbursement in Healthcare Implementation - Panel Discussion
11:00am Mike Standing, Partner, Monitor Deloitte

Real World Evidence in Healthcare; Transforming Patient Care

11:20am Kim Popovits, Chairman, CEO & President, Genomic Health

Building Evidence & Value Based Standards Needed to Guide Clinical Practice

11:40am Moderator:
Jennifer Hinkel, Partner, McGivney Global Advisors
Panelists:
Mike Standing, Partner, Monitor Deloitte
Kim Popovits, Chairman, CEO & President, Genomic Health
Richard Barker, Director, CASMI
Emerging Opportunities in Personalized Medicine
12:05pm Neil Campbell, M.B.A., President and CEO, Helomics

The Personalization of Healthcare and Helomics

12:15pm Sebastian Wernicke, Ph.D., Managing Director, Seven Bridges Genomics

Building Networks of Genomes

12:30pm Lunch Break hosted by Reed Elsevier
Emerging Opportunities in Personalized Medicine- Cnt'd
1:40pm Haim Gil-Ad, CEO, NovellusDx

NovellusDx Functional Oncogenic Activity Assay

1:50pm Frank S. Ong, M.D., Senior Director of Medical Affairs, QIAGEN

Scaling NGS Test Interpretation and Reporting in Oncology

2:05pm Niven Narain, Ph.D., Co-founder, President and CTO, Berg Health

Going Back to Patient Biology to Drive the Next Generation of Healthcare

2:15pm Vijay Chandru, Ph.D., FASc, FNAE, Chairman & CEO, Strand Life Sciences

Affordability as an Innovation Driver in Personalized Medicine

2:25pm Peter Donnelly, FRS, FMedSci, Co-founder, Genomics PLC.

Inference in Clinical Genomics

2:35pm Michael Ball, CEO, Genologics

The Impact of Informatics on Clinical NGS Services

2:45pm Cameron Frayling, Founder and CEO, Base4

A New Long-Read, Single-Molecule DNA Sequencing Chemistry

2:55pm Break
  Personalised Technologies/the Role of Technology in PM
3:40pm Sir Rory Collins, FRCP, FMedSci, Chief Executive, UK Biobank (Oxford)

UK Biobank: A Resource to Support Precision Medicine Research

4:00pm Euan Ashley, Ph.D., Director, Stanford Clinical Genomics Service

Towards Clinical Grade Whole Genome Sequencing

4:20pm Stefan Roever, Co-founder CEO, Genia (Roche Dx)

Charting the Course for Personalized Medicine with Nanopore Sequencing

4:40pm David R. Bentley, DPhil, FMedSci, Vice-President & Chief Scientist, Illumina Inc.

Genomes for Medicine

5:00pm Mark Caulfield, FRCP, FMedSci, Chief Scientist, Genomics England

Technology in the Healthcare Setting; the Scientific Challenges of the 100,000 Genome Project

5:20pm Closing

Day 3 - April 17, 2015

Time
 
8:30am Registration and Networking
Personalised Technologies - Cnt'd
8:50am Lee Hood, M.D., Ph.D., President, Institute for Systems Biology

Catalyzing a Revolution in Healthcare through a Longitudinal, Digital-Age Study of 100,000 Well Individuals

9:20am Clive Brown, Chief Technology Officer, Oxford Nanopore

Extending Nanopore Sensing Technology to Personalised Applications

9:40am Steve Picton, Ph.D., Director, Business Development-Europe, Pacific Biosciences

New Views of the Human Genome & Transcriptome through Long-Read Sequencing

10:00am Robert. Klein, Ph.D., Chief Business Officer, Complete Genomics, Inc.

Clinical Potential of Whole – Genome Sequencing

10:20am Break, Exhibition & Networking
Personalised Medicine and Big-data - Panel Discussion
10:50am Ketan Patel, Ph.D., Healthcare Solutions Consultant, Oracle Health Sciences

Challenges of Big-data and Genomics in the Clinic

11:05am Anne Wojcicki, CEO and Co-Founder, 23andMe

Genetics is Personal

11:20am Lee Hood, M.D., Ph.D., President, Institute for Systems Biology

P4 Medicine: the Challenges of Dynamic, Multi-scale Data Clouds for Individuals

11:35am Moderator:
Jonathan Sheldon, Ph.D., Global Vice President Health Sciences, Oracle
Panelists:
Ketan Patel, Ph.D., Healthcare Solutions Consultant, Oracle Health Sciences
Peter Paul Yu, M.D., President, ASCO
Lee Hood, M.D., Ph.D., President, Institute for Systems Biology
Peter Donnelly, FRS, FMedSci, Director, Wellcome Trust Centre for Human Genetics, Oxford University
Anne Wojcicki, CEO and Co-Founder, 23andMe
 
 
  Closing Talk
12:05pm Sir Mark Walport, FRS, FRCP, FRCPath, FMedSci, Chief Scientific Advisor, UK Government Science Office
12:30pm Peter Donnelly, FRS, FMedSci, Director, Wellcome Trust Centre for Human Genetics, Oxford University

Closing Remarks

12:35pm End of Program